Cargando…

SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine

This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.

Detalles Bibliográficos
Autores principales: Anderson, Mark, Stec, Michael, Rewane, Ayesan, Landay, Alan, Cloherty, Gavin, Moy, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346938/
https://www.ncbi.nlm.nih.gov/pubmed/34357399
http://dx.doi.org/10.1001/jamanetworkopen.2021.19741
_version_ 1783734962993758208
author Anderson, Mark
Stec, Michael
Rewane, Ayesan
Landay, Alan
Cloherty, Gavin
Moy, James
author_facet Anderson, Mark
Stec, Michael
Rewane, Ayesan
Landay, Alan
Cloherty, Gavin
Moy, James
author_sort Anderson, Mark
collection PubMed
description This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine.
format Online
Article
Text
id pubmed-8346938
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-83469382021-08-20 SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine Anderson, Mark Stec, Michael Rewane, Ayesan Landay, Alan Cloherty, Gavin Moy, James JAMA Netw Open Research Letter This cohort study examines antibody responses in infection-naive and previously infected individuals after 1 and 2 doses of the BNT162b2 vaccine. American Medical Association 2021-08-06 /pmc/articles/PMC8346938/ /pubmed/34357399 http://dx.doi.org/10.1001/jamanetworkopen.2021.19741 Text en Copyright 2021 Anderson M et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Anderson, Mark
Stec, Michael
Rewane, Ayesan
Landay, Alan
Cloherty, Gavin
Moy, James
SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title_full SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title_fullStr SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title_full_unstemmed SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title_short SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
title_sort sars-cov-2 antibody responses in infection-naive or previously infected individuals after 1 and 2 doses of the bnt162b2 vaccine
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346938/
https://www.ncbi.nlm.nih.gov/pubmed/34357399
http://dx.doi.org/10.1001/jamanetworkopen.2021.19741
work_keys_str_mv AT andersonmark sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine
AT stecmichael sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine
AT rewaneayesan sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine
AT landayalan sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine
AT clohertygavin sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine
AT moyjames sarscov2antibodyresponsesininfectionnaiveorpreviouslyinfectedindividualsafter1and2dosesofthebnt162b2vaccine